Sean Parker is a philanthropist and entrepreneur with a record of launching genre-defining companies and organizations. He is the founder and President of the Parker Foundation, which focuses on four areas: Life Sciences, Global Public Health, Civic Engagement, and the Arts.

In April 2016, the Parker Foundation announced a $250 million grant to form the Parker Institute for Cancer Immunotherapy, building on Mr. Parker’s leadership in funding and promoting research into the relationship between the immune system and cancer. In the ensuing years, the Parker Institute has evolved into a leader in the immunotherapy field for cutting edge research collaboration and clinical development, including funding a landmark human trial using CRISPR technology.